| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC0431 |
| Trial ID | NCT03502577 |
| Disease | Plasma Cell Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Suspended |
| Title | BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma |
| Year | 2018 |
| Country | United States |
| Company sponsor | Fred Hutchinson Cancer Center |
| Other ID(s) | 9952|NCI-2018-00514|9952|RG9218033 |
| Cohort 1 | |||||||||||||||||
|
|||||||||||||||||